Neostem (NYSE: NBS) is down 19 percent early after pricing an underwritten public offering of 20,000,000 shares of common stock ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE